(11bS)-2,6-Di-9-phenanthrenyl-4-hydroxy-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-oxide
(11bS)-2,6-Di-9-phenanthrenyl-4-hydroxy-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-oxide Basic information
- Product Name:
- (11bS)-2,6-Di-9-phenanthrenyl-4-hydroxy-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-oxide
- Synonyms:
-
- (11bS)-2,6-Di-9-phenanthrenyl-4-hydroxy-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-oxide
- (S)-3,3'-Bis(9-phenanthrenyl)-1,1'-binaphthyl-2,2'-diyl Hydrogen Phosphate
- SF110066
- (11bS)-2,6-Di-9-phenanthrenyl-4-hydroxy-4-oxidedinaphtho[ 2,1-d:1',2'-f][1,3,2]dioxaphosphepin
- (11bS)-2,6-Di-9-phenanthrenyl-4-hydroxy-4-oxidedinaphtho[ 2,1-d:1',2'-f][1,3,2]dioxaphosphepin,99%e.e.
- (11bS)-2,6-Di-9-phenanthrenyl-4-hydroxy-dinaphtho[2,1-d
- Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 4-hydroxy-2,6-di-9-phenanthrenyl-, 4-oxide, (11bS)-
- (S)-3,3'-Bis(9-phenanthryl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
- CAS:
- 1043567-32-3
- MF:
- C48 H29 O4 P
- MW:
- 700.72
- Mol File:
- 1043567-32-3.mol
More
Less
(11bS)-2,6-Di-9-phenanthrenyl-4-hydroxy-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-oxide Chemical Properties
- Density
- 1.46±0.1 g/cm3(Predicted)
- pka
- 1.11±0.20(Predicted)
(11bS)-2,6-Di-9-phenanthrenyl-4-hydroxy-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-oxideSupplier
Daicel Chiral Technologies (China)CO.,LTD
- Tel
- 021-50460086-9 15921403865
- han_yajun@dctc.daicel.com
Bide Pharmatech Ltd.
- Tel
- 400-164-7117 13681763483
- product02@bidepharm.com
Shanghai Chiral bio-compound co., Ltd.
- Tel
- 021-5068 3667/17749785980/1029026415; 17749785980
- 1029026415@qq.com
LaaJoo
- Tel
- 021-60702684 18516024827
- huang.jiayi@sinocompound.com
Greenherbs Science and Technology Development Co., Ltd.
- Tel
- 010-61136123
- pub02@greenherbs.com.cn
More
Less
(11bS)-2,6-Di-9-phenanthrenyl-4-hydroxy-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-oxide(1043567-32-3)Related Product Information
- (11bS)-4-Hydroxy-2,6-bis(4-methoxyphenyl)-4-oxidedinaphtho[ 2,1-d:1',2'-f][1,3,2]dioxaphosphepin
- R-4-oxide-4-hydroxy-2,6-bis(4-Methoxyphenyl)-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
- (R)-TRIP, (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin 4-oxide, (R)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-bi-2-naphthol cyclic monophosphate
- Ir(I)/(S)-t-Bu-PHOX
- R-3,3'-Bis(phenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
- (S)-TRIP, (11bS)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin 4-oxide, (S)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-bi-2-naphthol cyclic monophosphate
- R-4-oxide-4-hydroxy-2,6-di-2-naphthalenyl-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
- (11bR)-2,6-Di-9-phenanthrenyl-4-hydroxy-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-oxide
- (R)-3,3'-DIBROMO-2,2'-DIMETHOXY-1,1'-BINAPHTHYL
- S-3,3'-Bis(phenyl)-1,1'-bi-2-naphthol
- S-3,3'-diiodo-2,2'-bis(MethoxyMethoxy)1,1'-Binaphthalene
- 2-Methyl-1,1'-binaphthalene
- (1S)-3,3'-Di(phenanthren-9-yl)-1,1'-binaphthalene-2,2'-diol
- S-3,3'-bis([1,1'-biphenyl]-4-yl)-1,1'-Binaphthalene]-2,2'-diol
- S-3,3'-Bis(phenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
- (S)-3,3'-Dibromo-2,2'-bis(meth
- (11bS)-2,6-Di-1-pyrenyl-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
- (11bS) -2,6-Di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4- hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin